Nivestim™ in Treatment of Malignant Diseases

Clinical trial NCT01627990 · COMPLETED

Trial details

NCT number: NCT01627990
Sponsor: Hospira, now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Solid Tumour Malignant Haematological Tumour Primary or Secondary Prophylactic Treatment

Start date: 2011-06-01
Primary completion: 2013-12-01
Enrollment: 386

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.